По вашему запросу найдено документов: 8493
Страница 1 из 850
Treatment of atopic dermatitis with upadacitinib: adcare single center experience infections and the known risks of Janus kinase inhibitors, is essential. Further research is essential
JAK-STAT pathway in the vitiligo pathogenesis and therapy with Janus kinase inhibitors.Historical cases of the first patients treated with Janus kinase inhibitors initially used in rheumatoid arthritis
Novel therapeutic approaches for treatment of COVID-19Janus kinase inhibitor
Review of Small Molecule Anticancer NF-κB InhibitorsReview of Small Molecule Anticancer NF-κB Inhibitors
Potential uses of upadacitinib in rheumatoid arthritis and other inflammatory rheumatic diseases [ПЕРСПЕКТИВЫ ПРИМЕНЕНИЯ УПАДАЦИТИНИБА ПРИ РЕВМАТОИДНОМ АРТРИТЕ И ДРУГИХ ИММУНОВОСПАЛИТЕЛЬНЫХ РЕВМАТИЧЕСКИХ ЗАБОЛЕВАНИЯХ], which include Janus kinase (JAK) inhibitors. One representative of the class of JAK inhibitors
2-(2-(2,4-dioxopentan-3-ylidene)hydrazineyl)benzonitrile as novel inhibitor of receptor tyrosine kinase and PI3K/AKT/mTOR signaling pathway in glioblastoma exhibited the downregulation of cyclins, cyclin-dependent kinases and other key molecules involved in cell
Путь JAK-STAT в патогенезе витилиго и применения ингибиторов янус-киназ в качестве терапии.Historical cases of the first patients treated with Janus kinase inhibitors initially used in rheumatoid arthritis
Ингибиторы янус-киназ в терапии коморбидных заболеваний - атопического дерматита и гнездной алопеции: обзор литературы и опыт клинической практики in the case of association of these diseases. Janus-kinase inhibitors, which represent a new class of targeted
c-Jun N-terminal kinases (JNKs) in myocardial and cerebral ischemia/reperfusion injury and neuroprotective mechanisms of JNK inhibitors are discussed in detail including synthetic small molecule inhibitors
Immune pathogenesis of covid-19 intoxication: Storm or silence?Janus kinase inhibitor
Страница 1 из 850
Фасеты
Партнеры
Индексация
